Previous 10 |
Recent positive developments in COVID-19 vaccines have spurred a wave of market exuberance, lifting share prices of biotech companies at the forefront of the vaccine race. COVID-19 and the urgency to find a cure have opened up opportunities, making the biotech sector a prospective spa...
Annualized 2020 Return Since IBBJ’s Launch is 100.87% vs Nasdaq Biotech TR Index 5.77% IBBJ 20.83% (since inception) vs. Nasdaq Biotechnology TR Index 1.53% About Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered in...
News, Short Squeeze, Breakout and More Instantly...
Defiance Nasdaq Junior Biotechnology ETF Company Name:
IBBJ Stock Symbol:
NASDAQ Market:
Defiance Announces Fund Closure PR Newswire NEW YORK , Oct. 22, 2021 /PRNewswire/ -- Defiance ETFs announced today that the Board of Trustees of ETF Series Solutions (the "Trust") has determined to close and liquidate the Defiance Nasdaq Junior Biotechnology...
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants to invest in multiple biotech companies via one vehicle. The life science sector certainly holds a risk factor, and ETFs are a good wa...